Memorial Sloan Kettering Cancer Center
1275 York Avenue
149 articles with Memorial Sloan Kettering Cancer Center
Prostate cancer study with Serametrix in which data from a previous collaboration between Serametrix and Memorial Sloan Kettering Cancer Center (MSK) was re-evaluated using ITUS technology.
Personal Genome Diagnostics Expands Its Tumor Mutational Burden (TMB) Patent Portfolio for Cancer Immunotherapy
Personal Genome Diagnostics Inc. (PGDx) today announced an agreement with Memorial Sloan Kettering Cancer Center (MSK) for developing, registering, and commercializing products and services that include tumor mutation burden (TMB) biomarker status.
Elekta Collaborates With Leading New York Cancer Center to Continue Development of Clinical Protocols for MR-linac Technology
Elekta has entered into a research agreement with Memorial Sloan Kettering Cancer Center to investigate new treatment standards, imaging protocols, and treatment planning methodologies across various cancer indications.
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
The clinical objective is to use imaging as a precision medicine tool to rapidly determine an optimal therapeutic strategy for the patient.
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration With Major Cancer Center in HER2-Mutated Cancer
Daiichi Sankyo and Puma Biotechnology will co-sponsor the research.
PathoQuest Collaborating With Memorial Sloan Kettering Cancer Center to Study iDTECT Blood In Patients With Febrile Neutropenia
iDTECT Blood is the only CE-IVD NGS-based test which offers a culture-free, agnostic metagenomic approach to improving the breadth of pathogen detection.
OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York
ACEA Biosciences, Inc. Announces Collaboration With Memorial Sloan-Kettering Cancer Center On Personalized CAR T Cell Therapy
Royal Philips Electronics N.V. And Memorial Sloan-Kettering Cancer Center Announce Research Agreement To Jointly Develop Advanced Genome Analytics For Precision Oncology
MabVax Therapeutics Signs Research Agreement With Memorial Sloan-Kettering Cancer Center To Develop Novel CAR T-Cell Based Anti-Cancer Immunotherapies For Treatment Of Pancreatic And Small Cell Lung Cancers
Immune-Onc Therapeutics Announces Licensing And Collaboration With Albert Einstein College of Medicine And Memorial Sloan-Kettering Cancer Center To Develop Novel Cancer Immunotherapy
Karolinska Development AB Aprea Announces Research Collaboration With Memorial Sloan-Kettering Cancer Center
Lin Bioscience Licenses A Novel Anti-Cancer Therapy For Hematological Malignancies And Solid Tumors From Columbia University And Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center To Offer DigniCap Scalp Cooling Device In New York Metro Area Locations
Study From Memorial Sloan-Kettering Cancer Center And Epic Sciences Shows Only Nuclear-Localized AR-V7 Is Predictive Of Therapy Benefit For Patients With Metastatic Prostate Cancer
Multiple Myeloma Research Foundation (MMRF) And Memorial Sloan-Kettering Cancer Center Collaborate On Minimal Residual Disease (MRD) Study In Multiple Myeloma
Juno Announces Multiple Myeloma Partnership With Memorial Sloan-Kettering Cancer Center And Eureka Therapeutics For Developing CAR T Cell Immunotherapy Against Multiple Novel Targets
John R. Gunn, Former Chief Operating Officer Of Berkeley Lights, Joins Memorial Sloan-Kettering Cancer Center' Board Of Directors